The epidemiology of medically attended respiratory syncytial virus in older adults in the United States: A systematic review

PLoS ONE

Volumn 12, Issue 8, 2017, Pages

  Colosia, Ann D ^a   Yang, Jin ^a   Hillson, Eric ^b   Mauskopf, Josephine ^a   Copley Merriman, Catherine ^a   Shinde, Vivek ^b   Stoddard, Jeffrey ^b  

^a RTI HEALTH SOLUTIONS   (United States)

^b NOVAVAX INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE RESPIRATORY FAILURE; ADULT; AGE; ARTIFICIAL VENTILATION; COMORBIDITY; GRAFT RECIPIENT; HOSPITALIZATION; HUMAN; INCIDENCE; INTENSIVE CARE; LUNG TRANSPLANTATION; MORTALITY RATE; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVIEW; SYSTEMATIC REVIEW; UNITED STATES; WINTER; EPIDEMIOLOGY; MORTALITY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

HOSPITALIZATION; HUMANS; INCIDENCE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; UNITED STATES;

EID: 85027248138     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0182321     Document Type: Review

References (55)

1. Hall CB, Simoes EA, Anderson LJ. Clinical and epidemiologic features of respiratory syncytial virus. Curr Top Microbiol Immunol. 2013; 372: 39–57. https://doi.org/10.1007/978-3-642-38919-1_2 PMID: 24362683
2. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010; 375 (9725): 1545–1555. https://doi.org/10.1016/S0140-6736(10)60206-1 PMID: 20399493
3. Branche AR, Falsey AR. Respiratory syncytial virus infection in older adults: an under-recognized problem. Drugs Aging. 2015; 32 (4): 261–269. https://doi.org/10.1007/s40266-015-0258-9 PMID: 25851217
4. Falsey AR, McCann RM, Hall WJ, Tanner MA, Criddle MM, Formica MA, et al. Acute respiratory tract infection in daycare centers for older persons. J Am Geriatr Soc. 1995; 43 (1): 30–36. PMID: 7806736
5. Falsey AR, Treanor JJ, Betts RF, Walsh EE. Viral respiratory infections in the institutionalized elderly: clinical and epidemiologic findings. J Am Geriatr Soc. 1992; 40 (2): 115–119. PMID: 1740594
6. Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults. Clin Microbiol Rev. 2000; 13 (3): 371–384. PMID: 10885982
7. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005; 352 (17): 1749–1759. https://doi.org/10.1056/NEJMoa043951 PMID: 15858184
8. Falsey AR, McElhaney JE, Beran J, van Essen GA, Duval X, Esen M, et al. Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness. J Infect Dis. 2014; 209 (12): 1873–1881. https://doi.org/10.1093/infdis/jit839 PMID: 24482398
9. Jansen AG, Sanders EA, Hoes AW, van Loon AM, Hak E. Influenza- and respiratory syncytial virus-associated mortality and hospitalisations. Eur Respir J. 2007; 30 (6): 1158–1166. https://doi.org/10.1183/09031936.00034407 PMID: 17715167
10. Glenn GM, Smith G, Fries L, Raghunandan R, Lu H, Zhou B, et al. Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine. Vaccine. 2013; 31 (3): 524–532. https://doi.org/10.1016/j.vaccine.2012.11.009 PMID: 23153449
11. Langley JM, Sales V, McGeer A, Guasparini R, Predy G, Meekison W, et al. A dose-ranging study of a subunit respiratory syncytial virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults > or = 65 years of age. Vaccine. 2009; 27 (42): 5913–5919. https://doi.org/10.1016/j.vaccine.2009.07.038 PMID: 19651171
12. Falsey AR, Walsh EE, Capellan J, Gravenstein S, Zambon M, Yau E, et al. Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (RSV) vaccines—nonadjuvanted vaccine or vaccine adjuvanted with alum—given concomitantly with influenza vaccine to high-risk elderly individuals. J Infect Dis. 2008; 198 (9): 1317–1326. https://doi.org/10.1086/592168 PMID: 18855558
13. Falsey AR, Walsh EE. Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60. Vaccine. 1996; 14 (13): 1214–1218. PMID: 8961507
14. Haynes LM. Progress and challenges in RSV prophylaxis and vaccine development. J Infect Dis. 2013; 208 Suppl 3: S177–183.
15. Walsh EE, Peterson DR, Falsey AR. Is clinical recognition of respiratory syncytial virus infection in hospitalized elderly and high-risk adults possible? J Infect Dis. 2007; 195 (7): 1046–1051. https://doi.org/10.1086/511986 PMID: 17330796
16. Walsh EE, Falsey AR. Respiratory syncytial virus infection in adult populations. Infect Disord Drug Targets. 2012; 12 (2): 98–102. PMID: 22335500
17. Fowlkes A, Giorgi A, Erdman D, Temte J, Goodin K, Di Lonardo S, et al. Viruses associated with acute respiratory infections and influenza-like illness among outpatients from the influenza incidence surveillance project, 2010–2011. J Infect Dis. 2014; 209 (11): 1715–1725. https://doi.org/10.1093/infdis/jit806 PMID: 24338352
18. Talbot HK, Falsey AR. The diagnosis of viral respiratory disease in older adults. Clin Infect Dis. 2010; 50 (5): 747–751. https://doi.org/10.1086/650486 PMID: 20121411
19. Ginocchio C, McAdam A. Current best practices for respiratory virus testing. J Clin Microbiol. 2011; 49 (9 Suppl): S44–48.
20. McClure DL, Kieke BA, Sundaram ME, Simpson MD, Meece JK, Sifakis F, et al. Seasonal incidence of medically attended respiratory syncytial virus infection in a community cohort of adults 50 years old. PLoS One. 2014; 9 (7): e102586. https://doi.org/10.1371/journal.pone.0102586 PMID: 25025344
21. Bloom-Feshbach K, Alonso WJ, Charu V, Tamerius J, Simonsen L, Miller MA, et al. Latitudinal variations in seasonal activity of influenza and respiratory syncytial virus (RSV): a global comparative review. PLoS One. 2013; 8 (2): e54445. https://doi.org/10.1371/journal.pone.0054445 PMID: 23457451
22. Scottish Intercollegiate Guidelines Network. Critical appraisal: notes and checklists. 2007. Available from: http://www.sign.ac.uk/methodology/checklists.html. Cited 21 July 2016.
23. Widmer K, Griffin MR, Zhu Y, Williams JV, Talbot HK. Respiratory syncytial virus- and human metapneumovirus-associated emergency department and hospital burden in adults. Influenza Other Respir Viruses. 2014; 8 (3): 347–352. https://doi.org/10.1111/irv.12234 PMID: 24512531
24. Widmer K, Zhu Y, Williams JV, Griffin MR, Edwards KM, Talbot HK. Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J Infect Dis. 2012; 206 (1): 56–62. https://doi.org/10.1093/infdis/jis309 PMID: 22529314
25. Sumino KC, Walter MJ, Mikols CL, Thompson SA, Gaudreault-Keener M, Arens MQ, et al. Detection of respiratory viruses and the associated chemokine responses in serious acute respiratory illness. Thorax. 2010; 65 (7): 639–644. https://doi.org/10.1136/thx.2009.132480 PMID: 20627924
26. Walker E, Ison MG. Respiratory viral infections among hospitalized adults: experience of a single tertiary healthcare hospital. Influenza Other Respir Viruses. 2014; 8 (3): 282–292. https://doi.org/10.1111/irv.12237 PMID: 24490751
27. Wiemken T, Peyrani P, Bryant K, Kelley RR, Summersgill J, Arnold F, et al. Incidence of respiratory viruses in patients with community-acquired pneumonia admitted to the intensive care unit: results from the Severe Influenza Pneumonia Surveillance (SIPS) project. Eur J Clin Microbiol Infect Dis. 2013; 32 (5): 705–710. https://doi.org/10.1007/s10096-012-1802-8 PMID: 23274861
28. Zimmerman RK, Rinaldo CR, Nowalk MP, Balasubramani GK, Thompson MG, Moehling KK, et al. Influenza and other respiratory virus infections in outpatients with medically attended acute respiratory infection during the 2011–12 influenza season. Influenza Other Respir Viruses. 2014; 8 (4): 397–405. https://doi.org/10.1111/irv.12247 PMID: 24852890
29. Sundaram ME, Meece JK, Sifakis F, Gasser RA Jr., Belongia EA. Medically attended respiratory syncytial virus infections in adults aged 50 years: clinical characteristics and outcomes. Clin Infect Dis. 2014; 58 (3): 342–349. https://doi.org/10.1093/cid/cit767 PMID: 24265361
30. Falsey AR, Dallal GE, Formica MA, Andolina GG, Hamer DH, Leka LL, et al. Long-term care facilities: a cornucopia of viral pathogens. J Am Geriatr Soc. 2008; 56 (7): 1281–1285. https://doi.org/10.1111/j.1532-5415.2008.01775.x PMID: 18557966
31. Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA. 2000; 283 (4): 499–505. PMID: 10659876
32. Beckham JD, Cadena A, Lin J, Piedra PA, Glezen WP, Greenberg SB, et al. Respiratory viral infections in patients with chronic, obstructive pulmonary disease. J Infect. 2005; 50 (4): 322–330. https://doi.org/10.1016/j.jinf.2004.07.011 PMID: 15845430
33. Mehta J, Walsh EE, Mahadevia PJ, Falsey AR. Risk factors for respiratory syncytial virus illness among patients with chronic obstructive pulmonary disease. COPD. 2013; 10 (3): 293–299. https://doi.org/10.3109/15412555.2012.744741 PMID: 23536980
34. Martinello RA, Esper F, Weibel C, Ferguson D, Landry ML, Kahn JS. Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease. J Infect. 2006; 53 (4): 248–254. https://doi.org/10.1016/j.jinf.2005.11.010 PMID: 16412516
35. Weinberg A, Lyu DM, Li S, Marquesen J, Zamora MR. Incidence and morbidity of human metapneumovirus and other community-acquired respiratory viruses in lung transplant recipients. Transpl Infect Dis. 2010; 12 (4): 330–335. https://doi.org/10.1111/j.1399-3062.2010.00509.x PMID: 20456714
36. Milstone AP, Brumble LM, Barnes J, Estes W, Loyd JE, Pierson RN, 3rd, et al. A single-season prospective study of respiratory viral infections in lung transplant recipients. Eur Respir J. 2006; 28 (1): 131–137. https://doi.org/10.1183/09031936.06.00105505 PMID: 16510454
37. Lee FE, Walsh EE, Falsey AR. The effect of steroid use in hospitalized adults with respiratory syncytial virus-related illness. Chest. 2011; 140 (5): 1155–1161. https://doi.org/10.1378/chest.11-0047 PMID: 21565965
38. Camargo CA Jr., Ginde AA, Clark S, Cartwright CP, Falsey AR, Niewoehner DE. Viral pathogens in acute exacerbations of chronic obstructive pulmonary disease. Intern Emerg Med. 2008; 3 (4): 355–359. https://doi.org/10.1007/s11739-008-0197-0 PMID: 18825480
39. Branche AR, Walsh EE, Formica MA, Falsey AR. Detection of respiratory viruses in sputum from adults by use of automated multiplex PCR. J Clin Microbiol. 2014; 52 (10): 3590–3596. https://doi.org/10.1128/JCM.01523-14 PMID: 25056335
40. Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med. 2015; 373 (5): 415–427. https://doi.org/10.1056/NEJMoa1500245 PMID: 26172429
41. McCracken JP, Prill MM, Arvelo W, Lindblade KA, Lopez MR, Estevez A, et al. Respiratory syncytial virus infection in Guatemala, 2007–2012. J Infect Dis. 2013; 208 Suppl 3: S197–206.
42. Volling C, Hassan K, Mazzulli T, Green K, Al-Den A, Hunter P, et al. Respiratory syncytial virus infection-associated hospitalization in adults: a retrospective cohort study. BMC Infect Dis. 2014; 14: 665. https://doi.org/10.1186/s12879-014-0665-2 PMID: 25494918
43. Falsey AR, Formica MA, Hennessey PA, Criddle MM, Sullender WM, Walsh EE. Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006; 173 (6): 639–643. https://doi.org/10.1164/rccm.200510-1681OC PMID: 16387798
44. Family Caregiver Alliance. Selected long-term care statistics. 2015. Available from: https://www.caregiver.org/print/45. Cited 9 November 2016.
45. US Census Bureau. Community population survey: the older population in the United States: 2013. 2013. Available from: http://www.census.gov/population/age/data/2013.html. Cited 10 November 2016.
46. National Health Interview Survey, National Health and Nutrition Examination Survey, National Center for Health Statistics. National Heart, Lung, and Blood Institute fact book, fiscal year 2012: 4. Disease statistics data points for graphics. 2012. Available from: http://www.nhlbi.nih.gov/about/documents/factbook/2012/chapter4data#gr29. Cited 9 November 2016.
47. Wier LM, Elixhauser A, Pfuntner A, Au DH. Overview of hospitalizations among patients with COPD, 2008: statistical brief #106. In: Healthcare Cost and Utilization Project (HCUP) statistical briefs. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006.
48. Mohan A, Chandra S, Agarwal D, Guleria R, Broor S, Gaur B, et al. Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: a systematic review. Respirology. 2010; 15 (3): 536–542. https://doi.org/10.1111/j.1440-1843.2010.01722.x PMID: 20415983
49. Wu X, Chen D, Gu X, Su X, Song Y, Shi Y. Prevalence and risk of viral infection in patients with acute exacerbation of chronic obstructive pulmonary disease: a meta-analysis. Mol Biol Rep. 2014; 41 (7): 4743–4751. https://doi.org/10.1007/s11033-014-3345-9 PMID: 24691746
50. Zwaans WAR, Mallia P, van Winden MEC, Rohde GGU. The relevance of respiratory viral infections in the exacerbations of chronic obstructive pulmonary disease—a systematic review. J Clin Virol. 2014; 61 (2): 181–188. https://doi.org/10.1016/j.jcv.2014.06.025 PMID: 25066886
51. Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001; 164 (9): 1618–1623. https://doi.org/10.1164/ajrccm.164.9.2105011 PMID: 11719299
52. Dimopoulos G, Lerikou M, Tsiodras S, Chranioti A, Perros E, Anagnostopoulou U, et al. Viral epidemiology of acute exacerbations of chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 2012; 25 (1): 12–18. https://doi.org/10.1016/j.pupt.2011.08.004 PMID: 21983132
53. Wilkinson TM, Donaldson GC, Johnston SL, Openshaw PJ, Wedzicha JA. Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006; 173 (8): 871–876. https://doi.org/10.1164/rccm.200509-1489OC PMID: 16456141
54. Falsey AR, Walsh EE. Respiratory syncytial virus infection in elderly adults. Drugs Aging. 2005; 22 (7): 577–587. PMID: 16038573
55. Guan XR, Jiang LX, Ma XH, Wang LF, Quan H, Li HY. Respiratory syncytial virus infection and risk of acute myocardial infarction. Am J Med Sci. 2010; 340 (5): 356–359. https://doi.org/10.1097/MAJ.0b013e3181eecf29 PMID: 20811272